Hosp. Univ. Lucus Augusti

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma2 trials
• Head and neck cancer1 trial
• Lung cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 32 trials

Status

• Recruiting3 trials
• Completed2 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Janssen-Cilag Ltd.2 trials
• Johnson & Johnson Enterprise Innovation Inc.1 trial

Running trials

• Recruiting

  A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

  NCT07665450· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

  NCT07230691· Janssen Research & Development, LLC· Source

• Recruiting

  JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  NCT04892173· Phase 3· Johnson & Johnson Enterprise Innovation Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Multiple myeloma1 recruiting

Closed trials

• Completed

  A Real-world Study in Participants With Smoldering Multiple Myeloma

  NCT06472778· Janssen-Cilag Ltd.· Source

• Completed

  A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide

  NCT05901649· Janssen-Cilag Ltd.· Source